Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free

DRUG2 trials

Sponsors

Alcon Research

Conditions

Ocular Hyperemia

Phase 3

Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults

Not yet recruitingNCT07531043

Alcon ResearchOcular Hyperemia

Start: 2026-10-01End: 2027-02-01Target: 230Updated: 2026-08-27

An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults

Not yet recruitingNCT07578363

Alcon ResearchOcular Hyperemia

Start: 2026-09-01End: 2027-03-01Target: 178Updated: 2026-08-28